| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $117.7M | — | +39.0% |
| R&D Expense | $21.4M | — | +15.6% |
| SG&A Expense | $30.5M | — | +33.9% |
| Operating Income | $1.2M | — | +109.0% |
| Pre-tax Income | $2.8M | — | +127.0% |
| Income Tax | -$32K | — | -155.2% |
| Net Income | $2.8M | — | +127.1% |
| EPS (Basic) | $0.05 | — | +126.3% |
| EPS (Diluted) | $0.05 | — | +126.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $77.9M | +19.1% | -12.2% |
| Short-term Investments | $109.3M | -2.3% | -23.2% |
| Accounts Receivable | $44.6M | +4.6% | -37.6% |
| Inventory | $26.4M | -1.1% | +15.2% |
| Current Assets | $269.4M | +4.8% | -23.1% |
| Total Assets | $411.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4.3M | — | +116.3% |
| Capital Expenditures | $3.8M | — | +134.3% |
| Investing Cash Flow | $11.1M | — | +734.6% |
| Financing Cash Flow | -$2.9M | — | -352.7% |
| Free Cash Flow | $514K | — | +101.8% |
| -16.0% |
| Current Liabilities | $79.2M | -11.9% | -7.2% |
| Total Liabilities | $97.5M | -11.4% | -11.6% |
| Stockholders' Equity | $313.5M | +3.4% | -17.3% |